TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
INVO Fertility ( (IVF) ) has provided an update.
On September 8, 2025, INVO Fertility, Inc. saw an institutional investor exercise its Additional Investment Right to acquire 200 shares of Series C-2 Convertible Preferred Stock for $200,000. This transaction adjusted the conversion price to $0.7362 per share and was executed without registration under the Securities Act, relying on exemptions for non-public offerings.
The most recent analyst rating on (IVF) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
The overall stock score is primarily impacted by poor financial performance and bearish technical indicators. The company’s significant operational losses and high leverage pose substantial risks. The negative P/E ratio and lack of dividend yield further weaken the valuation. Despite a positive corporate event, the overall outlook remains challenging.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
Average Trading Volume: 1,589,876
Technical Sentiment Signal: Sell
Current Market Cap: $4.45M
See more data about IVF stock on TipRanks’ Stock Analysis page.